Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of quetiapine on delirium after coronary artery bypass graft surgery
IRCT20130525013456N7Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quetiapine in delirium, sponsored by Guilan University of Medical Sciences. Primary endpoint: Incidence of postoperative delirium. Started Aug 2023; status: completed.
02
Drugs
quetiapine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20130525013456N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130525013456N7.